Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to compare the efficacy of two inhalations of Symbicort Turbuhaler 160/4.5 µg/inhalation twice daily plus Symbicort Turbuhaler 160/4.5 µg/inhalation as-needed, with one inhalation of Seretide Diskus 50/500 µg/inhalation twice daily plus terbutaline Turbuhaler 0.4 mg/inhalation as-needed in patients with persistent asthma by evaluation of time to first severe asthma exacerbation as the primary outcome variable.
Critère d'inclusion
- This is a Phase IIIB study to be performed in adult and adolescent asthmatic patients